Advertisement

Topics

Newron to Participate in Upcoming Investor Conferences in November and December

07:00 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced ...

Other Sources for this Article

Newron
Stefan Weber, +39 02 6103 46 26
CEO
pr@newron.com
or
UK/Europe
FTI Consulting
Julia Phillips, +44 20 3727 1000
julia.phillips@FTIConsulting.com
or
Switzerland
IRF Communications
Martin Meier-Pfister, +41 43 244 81 40
martin.meier-pfister@irfcom.ch
or
Germany/Europe
MC Services
Anne Hennecke, +49 211 52925222
anne.hennecke@mc-services.eu
or
USA
LaVoieHealthScience
Beth Kurth, +1 617-374-8800, Ext. 106
bkurth@lavoiehealthscience.com

NEXT ARTICLE

More From BioPortfolio on "Newron to Participate in Upcoming Investor Conferences in November and December"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...